Some cancer drugs may cause people to develop autoimmune disease

As immunotherapies are increasingly used for a range of cancers, new cases of rheumatic disease are likely to emerge. INTRODUCTION Immune checkpoint inhibitors are a group of medicines used to treat some cancers. They work with a person’s immune system to fight the cancer. Immune checkpoint inhibitors include drugs called nivolumab (also known by its […]

Read More…

Ixekizumab: a new treatment option for people with PsA

Ixekizumab treatment resulted in improvements in disease activity and physical function in people with PsA. INTRODUCTION Psoriatic arthritis (often shortened to PsA) is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. The disease often causes swelling of the fingers and toes. It gets its name from the link between this […]

Read More…

Managing the use of glucocorticoid therapy in rheumatic disease

This is the patient version of the EULAR recommendations for the management of glucocorticoid medicines in people with rheumatic diseases. The original publication can be downloaded from the EULAR website: www.eular.org. INTRODUCTION Glucocorticoids (prednisone or prednisolone) are medicines to reduce inflammation. They are used in rheumatic diseases such as rheumatoid arthritis, polymyalgia, lupus and vasculitis […]

Read More…

Treatment-free remission may soon be a realistic goal in rheumatoid arthritis

Tapering and sometimes discontinuation of DMARDS is possible in people with rheumatoid arthritis who achieve sustained remission, hinting at the possibility that the disease could be cured. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that causes pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but […]

Read More…

Tofacitinib effective despite previous biologic therapy

Tofacitinib is effective in reducing the signs and symptoms of rheumatoid arthritis when used either before or after biologics. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but there is also a […]

Read More…

Low-dose methotrexate may be the best starting option for patients initiating treatment with adalimumab

Some medicines used to treat inflammatory diseases such as rheumatoid arthritis may have different efficacy and safety depending on the dose used. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Methotrexate is commonly used in patients with rheumatoid arthritis, both on its own and in combination […]

Read More…

Rituximab may reverse fibrosis in patients with systemic sclerosis

Rituximab may offer a new treatment option in patients with systemic sclerosis. INTRODUCTION Systemic sclerosis is a serious disease of the connective tissues, where the tissue grows abnormally and triggers the immune system to attack itself (autoimmunity). This can cause hardening (fibrosis) and swelling of the skin, as well as joint pain, digestive problems and […]

Read More…

Tocilizumab may increase the amount of cholesterol in the blood, but not the most damaging type of cholesterol

Some medicines used to treat inflammatory diseases such as rheumatoid arthritis may alter the balance of lipids and cholesterol in the blood. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. People with rheumatoid arthritis have an increased risk of suffering from cardiovascular diseases such as heart […]

Read More…